Innate Immunity to Adenovirus
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Human adenoviruses are the most widely used vectors in gene medicine, with applications ranging from oncolytic therapies to vaccinations, but adenovirus vectors are not without side effects. In addition, natural adenoviruses pose severe risks for immunocompromised people, yet infections are usually mild and self-limiting in immunocompetent individuals. Here we describe how adenoviruses are recognized by the host innate defense system during entry and replication in immune and nonimmune cells. Innate defense protects the host and represents a major barrier to using adenoviruses as therapeutic interventions in humans. Innate response against adenoviruses involves intrinsic factors present at constant levels, and innate factors mounted by the host cell upon viral challenge. These factors exert antiviral effects by directly binding to viruses or viral components, or shield the virus, for example, soluble factors, such as blood clotting components, the complement system, preexisting immunoglobulins, or defensins. In addition, Toll-like receptors and lectins in the plasma membrane and endosomes are intrinsic factors against adenoviruses. Important innate factors restricting adenovirus in the cytosol are tripartite motif-containing proteins, nucleotide-binding oligomerization domain-like inflammatory receptors, and DNA sensors triggering interferon, such as DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 and cyclic guanosine monophosphate-adenosine monophosphate synthase. Adenovirus tunes the function of antiviral autophagy, and counters innate defense by virtue of its early proteins E1A, E1B, E3, and E4 and two virus-associated noncoding RNAs VA-I and VA-II. We conclude by discussing strategies to engineer adenovirus vectors with attenuated innate responses and enhanced delivery features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 1×
“Both innate and adaptive immunity generally antagonize viral efficacy in gene therapy (reviewed in Janeway and Medzhitov, 2002; Fejer et al. , 2011; Russell et al. , 2012), although the treatment of aggressive forms of cancer by therapeutic viruses can be enhanced by the inflammatory host response…”
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 2×
“The mammalian homologs of the Drosophila TLRs are a class of PRRs detecting and responding to PAMPs and triggering innate immune reactions (Beutler et al. , 2006; Kawai and Akira, 2011; Thompson et al. , 2011).”
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576
Autophagy in immunity and inflammation
Levine, B., Mizushima, N., & Virgin, H. W. (2011) · Nature · doi:10.1038/nature09782 · Cited by 3,289 · cited 2×
“Second, E1-and E2-like activities of ATG7 and ATG3, respectively, lead to the conjugation of ATG8 homologs, for example, microtubule-associated protein 1A/1B-light chain 3 (LC3), with phosphatidyl-ethanolamine (Levine et al. , 2011).”
Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276 · cited 1×
“These serve for the elongation of the structure and loading of cargo that is bound to LC3-interacting proteins, such as p62 or Alfy (Bjørkøy et al. , 2005).”
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 2×
“The AIM2-like receptors (ALR) sense double-stranded DNA via the HIN200 domain of AIM2, and interact with the Caspase-1 adaptor protein via a PYD domain (Hornung et al., 2009).”
CGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING.
Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Röhl, I., Hopfner, K.-P., Ludwig, J., & Hornung, V. (2013) · Nature · doi:10.1038/nature12306 · Cited by 1,695 · cited 7×
“In mammalian cells, cGAMP binds the adaptor protein STING with high affinity, and leads to the activation of TBK1 and IRF3 and the production of IFN-b (Ablasser et al. , 2013a; Zhang et al. , 2013).”
InfluentialRussell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Autophagy‐based unconventional secretory pathway for extracellular delivery of IL‐1β
Dupont, N., Jiang, S., Pilli, M., Ornatowski, W., Bhattacharya, D., & Deretic, V. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.398 · Cited by 967
Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response
Saitoh, T., Fujita, N., Hayashi, T., Takahara, K., Satoh, T., Lee, H., Matsunaga, K., Kageyama, S., Omori, H., Noda, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911267106 · Cited by 854 · cited 1×
“Beyond controlling inflammasomes, TBK1 plays important roles in triggering innate immune responses against double-stranded DNA, which critically depends on STING (Saitoh et al. , 2009).”
Adenovirus oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex
Stracker, T. H., Carson, C. T., & Weitzman, M. D. (2002) · Nature · doi:10.1038/nature00863 · Cited by 522 · cited 1×
“…E4orf3, E1B-55K relocates the Mre11-Rad50-Nbs1 (MRN) complex and thereby precludes the formation of concatamers and DNA damage signaling during viral replication, thus increasing virus yield from infected cells (Stracker et al. , 2002, 2005; Evans and Hearing, 2003, 2005; Carson et al. , 2009).”
Self- and nonself-recognition by C-type lectins on dendritic cells
Geijtenbeek, T. B. H., van Vliet, S. J., Engering, A., 't Hart, B. A., & van Kooyk, Y. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104558 · Cited by 503 · cited 1×
“LRs are soluble proteins that can be released to the extracellular space, such as galectins (Gals) that bind to mannan sugars, or they are anchored in the plasma membrane, for example, the mannose-receptor dectin-1 (Geijtenbeek et al. , 2004; Cerliani et al. , 2011).”
Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α
Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A., & Livingston, D. M. (1996) · Nature · doi:10.1038/383344a0 · Cited by 493
Orzalli, M. H., DeLuca, N. A., & Knipe, D. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211302109 · Cited by 422 · cited 1×
“But for cytosolic DNA, the distinction by localization is not generally true, since DNA sensing occurs in both the nuclear and the cytosolic compartment, as shown for herpes virus (Li et al. , 2012; Orzalli et al. , 2012).”
Li, T., Diner, B. A., Chen, J., & Cristea, I. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203447109 · Cited by 297 · cited 2×
“But for cytosolic DNA, the distinction by localization is not generally true, since DNA sensing occurs in both the nuclear and the cytosolic compartment, as shown for herpes virus (Li et al. , 2012; Orzalli et al. , 2012).”
Gene Therapy with Viral Vectors
Kootstra, N. A., & Verma, I. M. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140257 · Cited by 267 · cited 1×
“They can be harnessed for gene therapy to introduce customized genes to diseased cells (Kootstra and Verma, 2003).”
Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis
Leopold, P. L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K. K., Rodriguez-Boulan, E., & Crystal, R. G. (2000) · Human Gene Therapy · doi:10.1089/10430340050016238 · Cited by 254 · cited 1×
“…virus reaches the cytosol, and uses dynein/dy-nactin and microtubule-based transport to reach the nuclear membrane (Suomalainen et al. , 1999, 2001; Leopold et al. , 2000; Mabit et al. , 2002; Strunze et al. , 2005; Bremner et al. , 2009; Gazzola et al. , 2009; Wodrich et al. , 2010; Engelke et…”
Cited by
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Duan, D. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.011 · Cited by 489
Slama, Y., Ah-Pine, F., Khettab, M., Arcambal, A., Begue, M., Dutheil, F., & Gasque, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713511 · Cited by 57
Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
Collignon, C., Bol, V., Chalon, A., Surendran, N., Morel, S., van den Berg, R. A., Capone, S., Bechtold, V., & Temmerman, S. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579872 · Cited by 29
Metadata
- Authors
- Hendrickx, R., Stichling, N., Koelen, J., Kuryk, L., Lipiec, A., & Greber, U. F.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2014-04
- Volume
- 25
- Issue
- 4
- Pages
- 265-284
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2069518974
- Cited by
- 217
- References
- 17
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.